Aleva Neurotherapeutics, Rheon Medical and VirtaMed reach the final
Aleva Neurotherapeutics presented their new generation of Deep Brain Stimulation systems which aim to improve therapy success rates, for example, in Parkinson’s patients. Rheon Medical submitted «eyeWatch», the world’s first non-invasive pressure equalization system expected to revolutionise the treatment of glaucoma. VirtaMed achieved the nomination with surgery simulators that enable doctors to train their surgical skills using virtual reality in a safe environment.
«I am continually impressed by the innovative power of the Swiss medical technology industry. These technical developments are only possible due to considerable work, perseverance, and passion. In addition, all three nominated companies have already achieved market success with their products» noted Swiss Medtech CEO Peter Biedermann regarding the jury’s decision.
A total of 27 applications were received for the Swiss Medtech Award 2020. The jurors evaluated the innovations in a two-stage process under the chairmanship of Prof. Mirko Meboldt, ETH Zurich. Criteria included patient benefits, contribution to improvements in healthcare, pioneering technological spirit, and entrepreneurial performance.
The award ceremony will take place during Swiss Medtech Day on 21 September 2020 in Bern. «Swiss Medtech Day is the most important event for the Swiss medical technology industry. It is therefore the perfect occasion to announce the winner and honour the achievements of the three nominees in front of an enthusiastic audience» says a pleased Peter Biedermann.
Swiss Medtech represents more than 600 members in its role as industry association for Swiss medical technology. With 58,500 employees and a contribution of 13.5% to the positive trade balance, medical technology is an economically significant sector in Switzerland. Swiss Medtech advocates for conditions that enable the medtech industry to perform at peak capacity and provide first-class medical care.